Boston Scientific
BSX
BSX
992 hedge funds and large institutions have $65.6B invested in Boston Scientific in 2023 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 388 increasing their positions, 317 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 91.18% → 91.34% (+0.16%)
11% less funds holding in top 10
Funds holding in top 10: 28 → 25 (-3)
24% less call options, than puts
Call options by funds: $210M | Put options by funds: $278M
Holders
992
Holding in Top 10
25
Calls
$210M
Puts
$278M
Top Buyers
| 1 | +$629M | |
| 2 | +$599M | |
| 3 | +$424M | |
| 4 |
Neuberger Berman Group
New York
|
+$253M |
| 5 |
Holocene Advisors
New York
|
+$218M |
Top Sellers
| 1 | -$688M | |
| 2 | -$562M | |
| 3 | -$420M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$124M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$123M |